HKEX · 01609
Company overview
HKEX disclosure extracts, revenue categories and field-level sources.
Text excerpts retain the original wording. Fields relate only to the periods or matters in their sources, without forecasts or new guidance. Revenue and shares reuse the financial dataset. HKEX originals and later disclosures take precedence.
Surgical Procedures · See repair principles and product roles
Company identity
- Chinese legal name
- 北京天星醫療股份有限公司
As stated in the 2026 interim report
2026 Interim Report · PDF 1 · printed — No printed page number. Reviewed 2026-10-01 - English legal name
- STAR SPORTS MEDICINE CO., LTD.
As stated in the 2026 interim report
2026 Interim Report · PDF 1 · printed — No printed page number. Reviewed 2026-10-01 - Listing date
- 5 May 2026
As stated in the 2026 interim report
2026 Interim Report · PDF 36 · printed 35 Reviewed 2026-10-01 - Stock exchange
- The Stock Exchange of Hong Kong Limited
As stated in the 2026 interim report
2026 Interim Report · PDF 36 · printed 35 Reviewed 2026-10-01 - Listing board
- Main Board
As stated in the 2026 interim report
2026 Interim Report · PDF 36 · printed 35 Reviewed 2026-10-01 - Stock code
- 01609
Stock Code
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS · PDF 1 · printed 1 Reviewed 2026-10-01 - Financial year end
- December 31
Financial years 2023, 2024 and 2025 in the prospectus
GLOBAL OFFERING · PDF 196 · printed 187 Reviewed 2026-10-01
Registration and audit
- Registered office
- Building 1, A018, B018
No. 25, Jinghai 2nd Road
Beijing Economic and Technological Development Zone
Beijing
PRCAs stated in the 2026 interim report
2026 Interim Report · PDF 4 · printed 03 Reviewed 2026-10-01 - Auditors
- Ernst & Young
As stated in the 2026 interim report
2026 Interim Report · PDF 4 · printed 03 Reviewed 2026-10-01
Business
- Business description (source excerpt)
- research and development and sales of innovative medical devices and equipment in the field of sports medicine
The Company and its subsidiaries, H1 2026
2026 Interim Report · PDF 36 · printed 35 Reviewed 2026-10-01
Revenue composition
RMB million. Share = category revenue / total revenue × 100%, rounded to one decimal place. Values and calculations reuse financial dataset 2026-09-30.1 · Figures & definitions
Revenue by product category
FY2023
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Medical implants | 186.516 | 78.2% | PDF 289 · printed I-24 ↗2026-09-30 |
| Surgical equipment and associated medical consumables | 51.919 | 21.8% | PDF 289 · printed I-24 ↗2026-09-30 |
| Others | 0.107 | 0.0% | PDF 289 · printed I-24 ↗2026-09-30 |
FY2024
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Medical implants | 249.987 | 76.4% | PDF 289 · printed I-24 ↗2026-09-30 |
| Surgical equipment and associated medical consumables | 76.986 | 23.5% | PDF 289 · printed I-24 ↗2026-09-30 |
| Others | 0.146 | 0.0% | PDF 289 · printed I-24 ↗2026-09-30 |
FY2025
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Medical implants | 310.375 | 77.1% | PDF 289 · printed I-24 ↗2026-09-30 |
| Surgical equipment and associated medical consumables | 92.020 | 22.8% | PDF 289 · printed I-24 ↗2026-09-30 |
| Others | 0.356 | 0.1% | PDF 289 · printed I-24 ↗2026-09-30 |
H1 2026
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Medical implants | 125.436 | 76.8% | PDF 40 · printed 39 ↗2026-09-30 |
| Surgical equipment and associated medical consumables | 37.815 | 23.1% | PDF 40 · printed 39 ↗2026-09-30 |
| Others | 0.176 | 0.1% | PDF 40 · printed 39 ↗2026-09-30 |
H1 2025 · Comparative
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Medical implants | 99.564 | 74.1% | PDF 40 · printed 39 ↗2026-09-30 |
| Surgical equipment and associated medical consumables | 34.703 | 25.8% | PDF 40 · printed 39 ↗2026-09-30 |
| Others | 0.111 | 0.1% | PDF 40 · printed 39 ↗2026-09-30 |
Revenue by customer location
FY2023
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Chinese mainland | 231.876 | 97.2% | PDF 289 · printed I-24 ↗2026-09-30 |
| Other countries/regions | 6.666 | 2.8% | PDF 289 · printed I-24 ↗2026-09-30 |
FY2024
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Chinese mainland | 306.267 | 93.6% | PDF 289 · printed I-24 ↗2026-09-30 |
| Other countries/regions | 20.852 | 6.4% | PDF 289 · printed I-24 ↗2026-09-30 |
FY2025
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Chinese mainland | 332.485 | 82.6% | PDF 289 · printed I-24 ↗2026-09-30 |
| Other countries/regions | 70.266 | 17.4% | PDF 289 · printed I-24 ↗2026-09-30 |
H1 2026
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Chinese mainland | 122.729 | 75.1% | PDF 40 · printed 39 ↗2026-09-30 |
| Other countries/regions | 40.698 | 24.9% | PDF 40 · printed 39 ↗2026-09-30 |
H1 2025 · Comparative
| Category | RMB million | Share (calculated) | Source / reviewed |
|---|---|---|---|
| Chinese mainland | 110.528 | 82.3% | PDF 40 · printed 39 ↗2026-09-30 |
| Other countries/regions | 23.850 | 17.7% | PDF 40 · printed 39 ↗2026-09-30 |
VOLUNTARY ANNOUNCEMENT SELECTED FOR INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX
- Announcement date
- August 24, 2026
Date on the announcement
VOLUNTARY ANNOUNCEMENT SELECTED FOR INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX · PDF 1 · printed — No printed page number. Reviewed 2026-10-01 - Index name
- Hang Seng Composite Index
Index identified in the inclusion announcement
VOLUNTARY ANNOUNCEMENT SELECTED FOR INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX · PDF 1 · printed — No printed page number. Reviewed 2026-10-01 - Effective date stated in the announcement
- September 7, 2026
Date stated in this announcement
VOLUNTARY ANNOUNCEMENT SELECTED FOR INCLUSION AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX · PDF 1 · printed — No printed page number. Reviewed 2026-10-01
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS
- Announcement date
- September 10, 2026
Date on the announcement
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS · PDF 2 · printed 2 Reviewed 2026-10-01 - Certificate
- EU Medical Device Regulation (CE MDR) certificate
Certificate received by the Company as stated in the announcement
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS · PDF 1 · printed 1 Reviewed 2026-10-01 - Product categories covered by the certificate
- 15
Limited to the certificate and product scope in the announcement; see the original list
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS · PDF 1 · printed 1 Reviewed 2026-10-01 - Exact certificate receipt date
- —
No exact date is stated; the announcement date is not used as a substitute.
The announcement says “recently”
VOLUNTARY ANNOUNCEMENT OBTAINING EU MDR CERTIFICATION AND PRODUCT REGISTRATION APPROVALS IN MULTIPLE OVERSEAS MARKETS · PDF 1 · printed 1 Reviewed 2026-10-01